Which single laboratory finding best distinguishes multiple myeloma from Waldenström macroglobulinemia in a 58-year-old Indian man presenting with bone pain and anemia?

Question

Accepted Answer

A. Serum monoclonal protein of IgM type. ## Distinguishing Multiple Myeloma from Waldenström Macroglobulinemia

### Key Discriminating Feature

**Key Point:** The immunoglobulin isotype is the most reliable discriminator between these two paraproteinemias. Multiple myeloma is predominantly IgG (50–60%) or IgA (20–25%), whereas Waldenström macroglobulinemia is **always IgM**.

### Comparison Table

| Feature | Multiple Myeloma | Waldenström Macroglobulinemia |
| --- | --- | --- |
| **Monoclonal protein isotype** | IgG, IgA, IgD, IgE (rarely IgM) | **IgM (100%)** |
| **Lytic bone lesions** | Present (CRAB criteria) | Absent (no bone involvement) |
| **Bone marrow plasma cells** | >30% (diagnostic) | <30%, mostly lymphoplasmacytoid cells |
| **Hyperviscosity** | Rare (IgG/IgA less viscous) | Common (IgM is pentameric, highly viscous) |
| **Organomegaly** | Absent | Common (splenomegaly, hepatomegaly) |
| **Lytic lesions vs. osteoporosis** | Punched-out lytic lesions | Generalized osteoporosis |

### Clinical Pearl

**Clinical Pearl:** IgM paraproteinemia in a patient with bone pain and lytic lesions is a **red flag for multiple myeloma, NOT Waldenström**. Conversely, IgM paraproteinemia with hyperviscosity and NO lytic lesions points to Waldenström.

### High-Yield Mnemonic

**Mnemonic:** **CRAB** = Calcium elevation, Renal insufficiency, Anemia, Bone lesions — these are the diagnostic criteria for symptomatic myeloma. Waldenström has none of these; instead it has **HVS** = Hyperviscosity, Villous lymphocytes, Splenomegaly.

### Why This Matters

Both conditions present with monoclonal paraproteinemia and bone marrow infiltration, but the **isotype of the monoclonal protein** is the single most reliable discriminator:
- **IgM → Waldenström** (by definition)
- **IgG/IgA/IgD/IgE → Multiple Myeloma** (IgM in myeloma is <1%)

This distinction is critical because treatment, prognosis, and complications differ significantly.

Answer

B. Lytic bone lesions on skeletal survey

Answer

C. Hyperviscosity syndrome

Answer

D. Bone marrow plasma cells >30%

Which single laboratory finding best distinguishes multiple myeloma from Waldenström macroglobulinemia in a 58-year-old Indian man presenting with bone pain and anemia?

Explanation

Distinguishing Multiple Myeloma from Waldenström Macroglobulinemia

Key Discriminating Feature

Comparison Table

Clinical Pearl

High-Yield Mnemonic

Why This Matters

Practice similar questions

Join our NEET PG community

Feature	Multiple Myeloma	Waldenström Macroglobulinemia
Monoclonal protein isotype	IgG, IgA, IgD, IgE (rarely IgM)	IgM (100%)
Lytic bone lesions	Present (CRAB criteria)	Absent (no bone involvement)
Bone marrow plasma cells	>30% (diagnostic)	<30%, mostly lymphoplasmacytoid cells
Hyperviscosity	Rare (IgG/IgA less viscous)	Common (IgM is pentameric, highly viscous)
Organomegaly	Absent	Common (splenomegaly, hepatomegaly)
Lytic lesions vs. osteoporosis	Punched-out lytic lesions	Generalized osteoporosis